The CINV Treatment Market demonstrates intricate segmentation based on drug class, route of administration, distribution channel, and region. 5-HT3 receptor antagonists and NK1 inhibitors hold major shares due to their proven efficacy. Hospitals and oncology clinics remain the largest end-user segment due to high patient volume and better access to care. As the healthcare sector evolves, new...